Cargando…
MicroRNA-608 promotes apoptosis via BRD4 downregulation in pancreatic ductal adenocarcinoma
The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains poor even among patients with the same Tumor-Node-Metastasis stage. Thus, it is necessary to identify biomarkers that can accurately predict outcomes. There is accumulating evidence suggesting that microRNA (miR) expression influences...
Autores principales: | Li, Maoyuan, Li, Ting, Ma, Weidong, Wang, Xiuchao, Zhao, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960394/ https://www.ncbi.nlm.nih.gov/pubmed/32002032 http://dx.doi.org/10.3892/ol.2019.11246 |
Ejemplares similares
-
The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma
por: Gao, Zhuqing, et al.
Publicado: (2019) -
Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes
por: Wang, Xiuchao, et al.
Publicado: (2016) -
Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma
por: Ni, Bo, et al.
Publicado: (2023) -
Inhibitory effect of microRNA-608 on lung cancer cell proliferation, migration, and invasion by targeting BRD4 through the JAK2/STAT3 pathway
por: Xu, Weigang, et al.
Publicado: (2020) -
Competing targets of microRNA-608 affect anxiety and hypertension
por: Hanin, Geula, et al.
Publicado: (2014)